H20.033

Secondary infectious iridocyclitis, bilateral

Billable code

This code does not map to a risk-adjusting HCC in the loaded models.

Coding notes

Excludes 1 never coded together · Excludes 2 may co-exist

Inherited from H20.0Acute and subacute iridocyclitis
Excludes 1

iridocyclitis, iritis, uveitis (due to) (in) diabetes mellitus (E08-E13 with .39) iridocyclitis, iritis, uveitis (due to) (in) diphtheria (A36.89) iridocyclitis, iritis, uveitis (due to) (in) gonococcal (A54.32) iridocyclitis, iritis, uveitis (due to) (in) herpes (simplex) (B00.51) iridocyclitis, iritis, uveitis (due to) (in) herpes zoster (B02.32) iridocyclitis, iritis, uveitis (due to) (in) late congenital syphilis (A50.39) iridocyclitis, iritis, uveitis (due to) (in) late syphilis (A52.71) iridocyclitis, iritis, uveitis (due to) (in) sarcoidosis (D86.83) iridocyclitis, iritis, uveitis (due to) (in) syphilis (A51.43) iridocyclitis, iritis, uveitis (due to) (in) toxoplasmosis (B58.09) iridocyclitis, iritis, uveitis (due to) (in) tuberculosis (A18.54)

Synonyms

Acute anterior uveitis Acute cyclitis Acute iritis Subacute anterior uveitis Subacute cyclitis Subacute iritis

Inherited from chapter 7Diseases of the eye and adnexa
Excludes 2

certain conditions originating in the perinatal period (P04-P96) certain infectious and parasitic diseases (A00-B99) complications of pregnancy, childbirth and the puerperium (O00-O9A) congenital malformations, deformations, and chromosomal abnormalities (Q00-Q99) diabetes mellitus related eye conditions (E09.3-, E10.3-, E11.3-, E13.3-) endocrine, nutritional and metabolic diseases (E00-E88) injury (trauma) of eye and orbit (S05.-) injury, poisoning and certain other consequences of external causes (S00-T88) neoplasms (C00-D49) symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94) syphilis related eye disorders (A50.01, A50.3-, A51.43, A52.71)

Note

Use an external cause code following the code for the eye condition, if applicable, to identify the cause of the eye condition

Official Guidelines for H20.033

FY 2026 ›